Dietary medium-chain triglyceride decanoate affects glucose homeostasis through GPR84-mediated GLP-1 secretion in mice
The 48-week data point At 48 weeks, participants in the 12 mg group had lost an average of 24.2% of body weight and the trajectory had not fully plateaued
This article breaks down the science, clinical trial results, and real-world experiences with these medications to help you understand their role in weight loss
Noom is built with long-term support in mind, so members can keep using behavior-change tools, lessons, tracking, coaching, recipes, and GLP-1 Companion features that support weight-loss maintenance
Nutritional markers should be selected according to intake, symptoms, and weight-loss trajectory